Skip to main content
Livermore
Livermore
中文EN

Oncotelic Therapeutics, Inc.

OTLC
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0000908259

In the last 90 days, Oncotelic Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Oncotelic Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
1 filing
1 insider, $10.3K in total
Open-market sells
0 filings
Insiders trading
1
Net value
+$10.3K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Oncotelic Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Oncotelic Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Fein Seymour HowardCRO/CMO–Jul 23, 20261
King Steven WDirector3,330,647IndirectJul 21, 20261
Maida Anthony E IIIDIRECTOR AND CMO - TRANS. MED.1,137,314Jul 14, 20261
Saund SaranCBO16,457,480Jul 14, 20261
Shah Amit B.CFO378,837Jul 14, 20262
Trieu VuongCHAIRMAN AND CEO94,124,319Jul 14, 20266
Diamond DavidDirector–Jul 16, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 2, 2026 (view filing)3:00 PM ETJul 11 dayTrieu VuongCHAIRMAN AND CEOPPurchase+240.0K$0.0431+$10.3K+0.3%94.1M after
Jun 24, 2026 (view filing)8:37 PM ETJun 22-242 daysTrieu VuongCHAIRMAN AND CEOPPurchase+255.0K$0.045+$11.5K+0.3%93.7M after3 lots
Jun 22, 2026 (view filing)4:30 PM ETJun 22Same dayShah Amit B.CFOPPurchase+20.0K$0.05+$1.00K+5.6%378.8K after
Jun 17, 2026 (view filing)7:34 PM ETJun 15-172 daysTrieu VuongCHAIRMAN AND CEOPPurchase+335.8K$0.0447+$15.0K+0.4%93.4M after2 lots
Jul 10, 2025 (view filing)5:15 PM ETJul 8-102 daysTrieu VuongCHAIRMAN AND CEOPPurchase+198.7K$0.005+$993.69+0.2%93.4M after3 lots
Jan 31, 2025 (view filing)5:08 PM ETJan 29-312 daysTrieu VuongCHAIRMAN AND CEOPPurchase+346.8K$0.028+$9.71K+0.4%93.2M after3 lots
Nov 26, 2024 (view filing)11:33 AM ETNov 224 daysTrieu VuongCHAIRMAN AND CEOPPurchase+298.5K$0.0289+$8.63K+0.3%92.8M after
Aug 27, 2024 (view filing)8:00 AM ETAug 234 daysTrieu VuongCHAIRMAN AND CEOPPurchase+500.0K$0.02+$10.0K+0.5%92.5M after
Jun 30, 2023 (view filing)9:25 AM ETJun 28-292 daysTrieu VuongCHAIRMAN AND CEOPPurchase+500.0K$0.0218+$10.9K+0.5%91.6M after2 lots
Jun 20, 2023 (view filing)12:00 PM ETJun 164 daysTrieu VuongCHAIRMAN AND CEOPPurchase+100.0K$0.026+$2.60K+0.1%91.5M after
Jun 16, 2023 (view filing)12:00 PM ETJun 142 daysTrieu VuongCHAIRMAN AND CEOPPurchase+400.0K$0.0326+$13.0K+0.4%91.4M after
May 31, 2023 (view filing)9:39 AM ETMay 265 daysTrieu VuongCHAIRMAN AND CEOPPurchase+126.9K$0.0341+$4.33K+0.1%91.0M after
May 2, 2023 (view filing)5:00 PM ETMay 2Same dayTrieu VuongCHAIRMAN AND CEOPPurchase+100.0K$0.045+$4.50K+0.1%90.9M after
Dec 7, 2022 (view filing)8:00 AM ETDec 61 dayTrieu VuongCHAIRMAN AND CEOPPurchase+120.0K$0.05+$6.00K+0.1%90.6M after
Nov 25, 2022 (view filing)9:00 AM ETNov 223 daysTrieu VuongCHAIRMAN AND CEOPPurchase+70.0K$0.08+$5.60K+0.1%90.4M after
Sep 28, 2022 (view filing)9:15 AM ETSep 262 daysTrieu VuongCHAIRMAN AND CEOPPurchase+20.0K$0.068+$1.36K0.0%90.4M after
Aug 29, 2022 (view filing)9:15 AM ETAug 254 daysTrieu VuongCHAIRMAN AND CEOPPurchase+80.0K$0.082+$6.56K+0.1%90.3M after